These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10563109)
21. Fluoroquinolones and their adverse effects. Girdhar BK Indian J Lepr; 1993; 65(1):69-79. PubMed ID: 8463726 [No Abstract] [Full Text] [Related]
22. New drugs and vaccines. Yeager H Dis Mon; 2007 Jan; 53(1):59-63. PubMed ID: 17224325 [No Abstract] [Full Text] [Related]
23. [Value of ciprofloxacin in the therapy of tuberculosis and other mycobacterioses]. Padeĭskaia EN Antibiot Khimioter; 1997; 42(6):15-25. PubMed ID: 9313055 [No Abstract] [Full Text] [Related]
24. Control of tuberculosis. Lancet; 1970 Aug; 2(7669):401-2. PubMed ID: 4194696 [No Abstract] [Full Text] [Related]
25. [Anti-retroviral treatment in patients with AIDS and mycobacterial diseases]. Corti ME; Palmero DJ Medicina (B Aires); 2005; 65(4):353-60. PubMed ID: 16193718 [TBL] [Abstract][Full Text] [Related]
27. New quinolones in clinical practice. MacGowan AP Hosp Med; 1999 Apr; 60(4):309. PubMed ID: 10396443 [No Abstract] [Full Text] [Related]
28. Pacemaker pocket infection due to Mycobacterium goodii: case report and review of the literature. Chrissoheris MP; Kadakia H; Marieb M; Libertin C Conn Med; 2008 Feb; 72(2):75-7. PubMed ID: 18306833 [No Abstract] [Full Text] [Related]
29. Quinolones and tuberculosis. Peloquin CA Ann Pharmacother; 1996 Sep; 30(9):1034-5. PubMed ID: 8876870 [No Abstract] [Full Text] [Related]
30. Quinolones in the treatment of gastrointestinal infections. Ramirez-Ronda C Chemioterapia; 1987 Jun; 6(2 Suppl):488-9. PubMed ID: 3334607 [No Abstract] [Full Text] [Related]
31. The potential of South African plants against Mycobacterium infections. McGaw LJ; Lall N; Meyer JJ; Eloff JN J Ethnopharmacol; 2008 Oct; 119(3):482-500. PubMed ID: 18805475 [TBL] [Abstract][Full Text] [Related]
32. Successful management of two heart transplant recipients with mycobacterial pulmonary infections. Bossert T; Bittner HB; Richter M; Rahmel A; Barten M; Gummert JF; Mohr FW Ann Thorac Surg; 2005 Aug; 80(2):719-21. PubMed ID: 16039241 [TBL] [Abstract][Full Text] [Related]
33. The chemoprophylaxis of mycobacterial diseases. Long ER Int J Lepr Other Mycobact Dis; 1966; 34(1):65-7. PubMed ID: 5949000 [No Abstract] [Full Text] [Related]
35. Pacemaker infections due to rapidly growing mycobacteria: further experience. Tam WO; Yew WW; Yam WC; Yuen KY; Wong PC; Tse TF Int J Tuberc Lung Dis; 2007 Jan; 11(1):118. PubMed ID: 17217143 [No Abstract] [Full Text] [Related]
36. [New quinolones for the treatment of community-acquired pneumonia--pro]. Zimmerli S Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859 [No Abstract] [Full Text] [Related]
37. Mutant prevention concentration: a new tool for choosing treatment in nontuberculous mycobacterial infections. Rodríguez JC; Cebrián L; López M; Ruiz M; Royo G Int J Antimicrob Agents; 2004 Oct; 24(4):352-6. PubMed ID: 15380260 [TBL] [Abstract][Full Text] [Related]
38. Non-tuberculous mycobacterial infections in the Scottish Borders. Bredin CP J R Coll Physicians Edinb; 2012 Mar; 42(1):93. PubMed ID: 22441076 [No Abstract] [Full Text] [Related]
39. Inadvertent use of ciprofloxacin as a single agent in undiagnosed tuberculosis. Khilnani G; Gupta RC J Assoc Physicians India; 1998 Apr; 46(4):401. PubMed ID: 11273333 [No Abstract] [Full Text] [Related]
40. [Are quinolones the drugs of choice in pneumonia caused by microorganisms of Legionella genus?]. Bouza Santiago E; Rodríguez-Créixems M Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():19-23. PubMed ID: 10563106 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]